COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,931 | -99.2% | 1,155 | -98.7% | 0.00% | -100.0% |
Q1 2023 | $600,893 | -16.2% | 87,850 | -2.9% | 0.00% | 0.0% |
Q4 2022 | $716,711 | -9.2% | 90,494 | +9.9% | 0.00% | -50.0% |
Q3 2022 | $789,000 | +1.0% | 82,353 | -23.8% | 0.00% | 0.0% |
Q2 2022 | $781,000 | +181.9% | 108,042 | +402.5% | 0.00% | – |
Q1 2022 | $277,000 | -71.5% | 21,500 | -67.7% | 0.00% | -100.0% |
Q1 2021 | $971,000 | -38.5% | 66,535 | -26.8% | 0.00% | -33.3% |
Q4 2020 | $1,578,000 | +31.2% | 90,851 | +38.3% | 0.00% | 0.0% |
Q3 2020 | $1,203,000 | +31.5% | 65,682 | +28.1% | 0.00% | +50.0% |
Q2 2020 | $915,000 | -8.7% | 51,289 | -16.9% | 0.00% | -33.3% |
Q1 2020 | $1,002,000 | +51.4% | 61,756 | +67.8% | 0.00% | +200.0% |
Q4 2019 | $662,000 | -67.3% | 36,800 | -63.2% | 0.00% | -75.0% |
Q3 2019 | $2,026,000 | +2311.9% | 100,004 | +1598.4% | 0.00% | – |
Q2 2017 | $84,000 | -84.6% | 5,888 | -77.1% | 0.00% | -100.0% |
Q1 2017 | $545,000 | -48.0% | 25,727 | -30.7% | 0.00% | -50.0% |
Q4 2016 | $1,048,000 | – | 37,117 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |